Work

Fatty Liver Index and Differential Glycemic Responses to Ipragliflozin Versus Sitagliptin Over 52 Weeks: An Exploratory Post Hoc Analysis of the Niigata Ipragliflozin and Sitagliptin With Metformin (N‐ ISM ) Study

Year: 2026

Type: article

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.71211

Authors: Masaru Kitazawa, Takashi Katagiri, Hiromi Suzuki, Mayuko Yamada, Mariko Hatta, Hiroki Takizawa, Koshiro Murai, Takaaki Sato, Yasuhiro Matsubayashi, Takaho Yamada, Shiro Tanaka, Hirohito Sone

Institutions: Niigata University, Kashiwazaki General Hospital and Medical Center, Nagaoka Red Cross Hospital, Kyoto University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Astellas Pharma

OpenAlex ID: W7203640644

FWCI:

Cites: 34

Cited by:

Related to: